Last reviewed · How we verify
TRX-818 capsules
At a glance
| Generic name | TRX-818 capsules |
|---|---|
| Sponsor | TaiRx, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety and Pharmacokinetic Study of CVM-1118 Extended-Release in Advanced Cancer Patients (PHASE1)
- A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Cancer (PHASE1)
- Safety and Pharmacokinetic Study of TRX-818 in Asian Solid Tumor Patients (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |